期刊文献+

川崎病患儿FCGR2A基因单核苷酸多态性的研究 被引量:9

Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease
原文传递
导出
摘要 目的探讨中国汉族儿童FCGR2A基因rs1801274位点单核苷酸多态性(SNP)与川崎病(KD)易感性及静脉注射免疫球蛋白(IVIG)治疗KD疗效的关系。方法应用聚合酶链反应(PCR)联合直接基因测序技术对35例KD患儿和25例健康儿童的FCGR2A基因SNP rs1801274位点进行检测和分析,并将KD患儿根据IVIG治疗后有无并发冠脉损害(CAL)分为CAL和无CAL(NCAL)两个亚组。结果在研究对象中均检测到FCGR2A基因rs1801274位点,该位点存在3种基因型(AA、AG、GG)。该SNP位点的基因型分布及等位基因频率在KD组与对照组及CAL组与NCAL组之间比较差异均有统计学意义(P<0.05)。其中携带A等位基因或AA基因型者发生KD的危险性大(分别OR=3.39,95%CI:1.53~7.50;OR=4.93,95%CI:1.61~15.1);携带基因型AG或G等位基因使KD患儿发生CAL的危险性增高(分别OR=5.43,95%CI:1.06~27.8;OR=4.88,95%CI:1.44~16.5)。结论 FCGR2A基因rs1801274位点SNP可能是影响中国汉族儿童KD易感性以及IVIG治疗KD疗效的一个重要因素。 Objective To study the association of FCGR2A gene single nucleotide polymorphism (SNP) rs1801274 with Kawasaki disease (KD) susceptibility and the efficacy of intravenous immunoglobulin (IVIG) therapy in Han Chinese children. Methods Thirty-five KD children and 25 age-and gender-matched healthy children (control group ) were enrolled in the study. Polymerase chain reaction ( PCR ) and gene sequence analysis were applied to detect SNP of FCGR2A gene rs1801274. These KD patients were classified into two subgroups based on the presence of coronary artery lesion (CAL) following IVIG therapy: CAL (n = 13) and non-CAL (n =22). Results FCGR2A gene SNP rs1801274 was detected in all subjects, including three genotypes (AA, AG and GG). For FCGR2A gene SNP rs1801274, there were significant differences in the genotype and allele frequencies between the KD and control groups (P 〈 0.05 ), and significant differences' in the genotype and allele frequencies were also found between the CAL and non-CAL subgroups (P 〈 0.05 ). A allele and AA genotype were linked to an increased risk of KD susceptibility (A allele: OR = 3.39, 95% CI: 1.53 -7.50;AA genotype: OR = 4.93, 95% CI: 1.61 - 15.1 ). Both AG ( OR = 5.43, 95% CI: 1.06 - 27.8 ) and G allele ( OR = 4.88, 95% CI: 1.44 - 16.5 ) were linked to an increased risk of CAL in KD children. Conehlsions Polymorphism of the FCGR2A gene SNP rs1801274 is one of the important factors probably influencing susceptibility to KD and efficacy of IVIG therapy on KD in Han Chinese children.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2013年第3期196-200,共5页 Chinese Journal of Contemporary Pediatrics
基金 天津市卫生局科技基金攻关项目(No.11KG119)
关键词 FCGR2A基因 川崎病 冠状动脉损伤 单核苷酸多态性 静脉注射免疫球蛋白 儿童 FCGR2A gene Kawasaki disease Coronary artery lesion Single nucleotide polymorphism Intravenous immunoglobulin Child
  • 相关文献

参考文献22

  • 1Wallace CA,French JW,Kahn SJ,Sherry DD.Initial intravenousgammaglobulin treatment failure in Kawasaki disease[J].Pediat-rics,2000,105(6):E78.
  • 2Kazatchkine MD,Kaveri SV.Immunomodulation of autoimmuneand inflammatory diseases with intravenous immune globulin[J].NEngl Med,2001,345(10):747-755.
  • 3张艳涛,谢利剑,黄敏,沈捷,李锦康.大剂量丙种球蛋白对川崎病肾上腺髓质素及相关基因表达的影响[J].临床儿科杂志,2012,30(1):84-88. 被引量:7
  • 4Abe J,Jibiki T,Noma S,Nakajima T,Saito H,Terai M.Geneexpression profiling of the effect of high-dose intravenous Ig in pa-tients with Kawasaki disease[J].J Immunol,2005,174(9):5837-5845.
  • 5Taniuchi S,Masuda M,Teraguchi M,Ikemoto Y,Komiyama Y,Takahashi H,et al.Polymorphism of fcgamma riia may affect theefficacy of gamma-globulin therapy in Kawasaki disease[J].ClinImmunol,2005,25(4):309-313.
  • 6Biezeveld M,Geissler J,Merkus M,Kuipers IM,Ottenkamp J,Kuijpers T.The involvement of fc gamma receptor gene polymor-phisms in kawasaki disease[J].Clin Exp Immunol,2006,147(1):106-111.
  • 7Khor CC,Davila S,Breunis WB,Lee YC,Shimizu C,WrightVJ,et al.Genome-wide association study identifies FCGR2A as asusceptibility locus for Kawasaki disease[J].Nat Genet,2011,43(12):1241-1246.
  • 8Lee YC,Kuo HC,Chang JS,Chang LY,Huang LM,Chen MR,et al.Two new susceptibility loci for Kawasaki disease identifiedthrough genome-wide association analysis[J].Nat Genet,2012,44(5):522-525.
  • 9Onouchi Y,Ozaki K,Burns JC,Shimizu C,Terai M,Hamada第15卷第3期2013年3月中国当代儿科杂志Chin J Contemp PediatrVol.15 No.3Mar.2013H,et al.A genome-wide association study identifies three newrisk loci for Kawasaki disease[J].Nat Genet,2012,44(5):517-521.
  • 10Shrestha S,Wiener H,Shendre A,Kaslow RA,Wu J,Olson A,et al.Role of activating FcγR gene polymorphisms in Kawasaki dis-ease susceptibility and intravenous immunoglobulin response[J].Circ Cardiovasc Genet,2012,5(3):309-316.

二级参考文献24

  • 1Ikeda K,Ihara K,Yamaguchi K,et al.Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease[J].Pediatr Res,2008,63(2):182-185.
  • 2Huang Y,Lee YJ,Chen MR,et al.Polymorphism of transmembrane region of MICA gene and Kawasaki disease[J].Exp Clin Immunogenet,2000,17(3):130-137.
  • 3Jin HS,Kim HB,Kim BS,et al.The IL-10(-627A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease[J].Pediatr Res,2007,61(5 Pt 1):584-587.
  • 4Nomura I,Abe J,Noma S,et al.Adrenomedullin is highly expressed in blood monocytes associated with acute Kawa-saki disease:a microarray gene expression study[J].Pediatr Res,2005,57(1):49-55.
  • 5Newbugger JW,Takahashi M,Beiser AS,et al.A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki Syn-drome[J].N Engl J Med,1991,324(23):1633-1639.
  • 6Toyoda M,Pao A,Petrosian A,et al.Pooled human immune globulin (IVIG) modulates surface molecule expres-sion and induces apoptosis in human B-cells[J].Am J Tran-splant,2003,3(2):156-166.
  • 7Jordan SC,Vo AA,Peng A,et al.Intravenous gamma-globulin (IVIG):a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients[J].Am J Transplant,2006,6(3):459-466.
  • 8Samuelsson A,Towers TL,Ravetch JV.Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor[J].Science,2001,291(5503):484-486.
  • 9Kazatchkine MD,Kaveri SV.Immunomodulation of auto-immune and inflammatory diseases with intravenous immune globulin[J].N Engl J Med,2001,345(10):747-755.
  • 10Lutz H,Stammler P,Bianchi V,et al.Intravenously applied IgG stimulates complement attenuation in a comple-ment-dependent auto-immune disease at the amplifying C3 convertase level[J].Blood,2004,103(2):465-472.

共引文献6

同被引文献101

  • 1Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [ in Japanese ] [J]. Arerugi, 1967,16 (3) : 178-222.
  • 2Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endo- carditis an Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [ J ]. Pediatrics, 2004, 114 (6) :1708-1733.
  • 3Egami K, Muta H, Ishii M, et al. Predication of resistance to intrave- nous immunoglobulin treatment in patients with Kawasaki disease [J]. J Pediatr,2006,149(2) :237-240.
  • 4Kobayashi T, Inoue Y, Takeuchi, et al. Predication of intravenous im- munoglobulin unresponsiveness in patients with Kawasaki disease [J]. Circulation ,2006,113 ( 22 ) :2606-2612.
  • 5Sano T, Kurotobi S, Matsuzaki K, et al. Predication of non-respon- siveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment [ J]. Eur J Pediatr,2007,116 (2) :131-137.
  • 6Sleeper LA, Minich LL, McCrindie BM, et al. Evaluation of Kawasa- ki disease risk scoring system for intravenous immunoglobulin resist- ance[ J]. J Pediatr,2011,158 (5) :831-835.
  • 7Nakamura Y, Yshiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan : result of the 2007-2008 nationwide survey[ J ]. J Epidemiol,2010,20 (4) : 302 -307.
  • 8Uehara R, Belay ED, Maddox RA, et al. A analysis of potential risk factors associated with nonresponse to initial intravenous immuno- globulin treatment among Kawasaki disease patients in Japan[ J]. Pe-diatr infect Dis J,2008,27 ( 2 ) : 155-160.
  • 9Fukunishi M, Kikkawa M, Hamana K, et al. Predication of non-re- sponsiveness to intravenous high-dose gamma-globulin therapy in pa- tients with Kawasaki disease at onset [ J ]. J Pediatr, 2000,137 ( 2 ) : 172-176.
  • 10Seki M, Kobayashi T, Kobayashi T, et al. External validation of risk score to predict intravenous immunoglobulin resistance in patients with Kawasaki disease[ J ]. Pediatr infect Dis J,2011,30 (2) : 145-147.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部